Salahop, Judie C.

HRN: 16-69-61  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2026
CEFTRIAXONE 1G (VIAL)
02/02/2026
02/09/2026
IV
2g
Q24
Stab Wound Abdomen
Waiting Final Action 
02/02/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/02/2026
03/09/2026
IV
500mg
Q8
Stab Wound
Waiting Final Action 
02/03/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/03/2026
03/10/2026
IV
4.5g
Q8h
Stab Wound
Remove - Pending Acceptance
02/19/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
02/19/2026
02/26/2026
IV
500mg
OD
S/P Exlap #3
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: